Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer

Por Sinicrope, Frank A., Okamoto, Koichi, Kasi, Pashtoon M., Kawakami, Hisato
Publicado no Clin Gastroenterol Hepatol (2016)

Blinding Trachoma: A Disease of Poverty

Por Kasi, Pashtoon M, Gilani, Ahmed I, Ahmad, Khabir, Janjua, Naveed Z
Publicado em 2004

Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective

Por Kasi, Pashtoon M, Tawbi, Hussein A, Oddis, Chester V, Kulkarni, Hrishikesh S
Publicado em 2012

Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets

Por Kasi, Pashtoon M., Litzow, Mark R., Patnaik, Mrinal M., Hashmi, Shahrukh K., Gangat, Naseema
Publicado no Leuk Res Rep (2016)

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study

Por Kasi, Pashtoon M., Kotani, Daisuke, Cecchini, Michael, Shitara, Kohei, Ohtsu, Atsushi, Ramanathan, Ramesh K., Hochster, Howard S., Grothey, Axel, Yoshino, Takayuki
Publicado no BMC Cancer (2016)

Establishing Magnetic Resonance Imaging as an Accurate and Reliable Tool to Diagnose and Monitor Esophageal Cancer in a Rat Model

Por Kosovec, Juliann E., Zaidi, Ali H., Komatsu, Yoshihiro, Kasi, Pashtoon M., Cothron, Kyle, Thompson, Diane V., Lynch, Edward, Jobe, Blair A.
Publicado em 2014

A Proof-of-Concept Trial of Protein Kinase C Iota Inhibition with Auranofin for the Paclitaxel-Induced Acute Pain Syndrome

Por Jatoi, Aminah, Grudem, Megan E., Dockter, Travis J., Block, Matthew S., Villasboas, Jose C., Tan, Angelina, Deering, Erin, Kasi, Pashtoon M., Mansfield, Aaron S., Botero, Juliana Perez, Okuno, Scott H., Smith, Deanne R., Fields, Alan P.
Publicado no Support Care Cancer (2016)

Prognostic Value and Targeted Inhibition of Survivin Expression in Esophageal Adenocarcinoma and Cancer-Adjacent Squamous Epithelium

Por Malhotra, Usha, Zaidi, Ali H., Kosovec, Juliann E., Kasi, Pashtoon M., Komatsu, Yoshihiro, Rotoloni, Christina L., Davison, Jon M., R, Clint, Irvin, Hoppo, Toshitaka, Nason, Katie S., Kelly, Lori A., Gibson, Michael K., Jobe, Blair A.
Publicado em 2013

Evaluation of a four-protein serum biomarker panel – biglycan, annexin-A6, myeloperoxidase and protein S100-A9 (B-AMP©) – for detection of esophageal adenocarcinoma

Por Zaidi, Ali H., Gopalakrishnan, Vanathi, Kasi, Pashtoon M., Zeng, Xuemei, Malhotra, Usha, Balasubramanian, Jeya, Visweswaran, Shyam, Sun, Mai, Flint, Melanie S., Davison, Jon M., Hood, Brian L., Conrads, Thomas P., Bergman, Jacques J., Bigbee, William L., Jobe, Blair A.
Publicado no Cancer (2014)

MicroRNA Signature Characterizes Primary Tumors That Metastasize in an Esophageal Adenocarcinoma Rat Model

Por Zaidi, Ali H., Saldin, Lindsey T., Kelly, Lori A., Bergal, Linda, Londono, Ricardo, Kosovec, Juliann E., Komatsu, Yoshihiro, Kasi, Pashtoon M., Shetty, Amit A., Keane, Timothy J., Thakkar, Shyam J., Huleihel, Luai, Landreneau, Rodney J., Badylak, Stephen F., Jobe, Blair A.
Publicado no PLoS One (2015)

Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma

Por Zaidi, Ali H., Kelly, Lori A., Kreft, Rachael E., Barlek, Mark, Omstead, Ashten N., Matsui, Daisuke, Boyd, Natalie H., Gazarik, Kathryn E., Heit, Megan I., Nistico, Laura, Kasi, Pashtoon M., Spirk, Tracy L., Byers, Barbara, Lloyd, Emily J., Landreneau, Rodney J., Jobe, Blair A.
Publicado no BMC Cancer (2016)